We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NET icon
401
Cloudflare
NET
$96B
$2.6M 0.02%
41,178
+314
+0.8% +$20.1K
ATO icon
402
Atmos Energy
ATO
$29.7B
$2.58M 0.02%
24,335
PINS icon
403
Pinterest
PINS
$13.7B
$2.56M 0.02%
94,836
+1,173
+1% +$32K
FDMT icon
404
4D Molecular Therapeutics
FDMT
$502M
$2.52M 0.02%
198,000
+25,000
+14% +$418K
LYV icon
405
Live Nation Entertainment
LYV
$42.9B
$2.51M 0.02%
30,199
-749
-2% -$65.3K
NUE icon
406
Nucor
NUE
$58.3B
$2.48M 0.02%
15,838
-626
-4% -$104K
ZBRA icon
407
Zebra Technologies
ZBRA
$13.5B
$2.44M 0.02%
68,487
+993
+1% +$270K
CHTR icon
408
Charter Communications
CHTR
$17.3B
$2.41M 0.02%
5,489
+258
+5% +$107K
COF icon
409
Capital One
COF
$128B
$2.4M 0.02%
24,685
-20,334
-45% -$2.17M
PPG icon
410
PPG Industries
PPG
$24.9B
$2.39M 0.02%
18,384
-38
-0.2% -$5.33K
EWC icon
411
iShares MSCI Canada ETF
EWC
$6.12B
$2.38M 0.02%
71,200
-25,967
-27% -$900K
CMI icon
412
Cummins
CMI
$83.6B
$2.37M 0.02%
10,366
-70
-0.7% -$16.9K
STZ icon
413
Constellation Brands
STZ
$22.5B
$2.35M 0.02%
9,357
-1,198
-11% -$313K
RL icon
414
Ralph Lauren
RL
$22.4B
$2.33M 0.02%
20,093
-74,110
-79% -$8.97M
CEG icon
415
Constellation Energy
CEG
$92.1B
$2.32M 0.02%
21,246
-14,442
-40% -$1.49M
LRN icon
416
Stride
LRN
$4.16B
$2.31M 0.02%
51,239
-2,903
-5% -$118K
EQR icon
417
Equity Residential
EQR
$25.8B
$2.29M 0.02%
39,051
-197,629
-84% -$12.8M
ROST icon
418
Ross Stores
ROST
$80.8B
$2.28M 0.02%
20,188
-2,013
-9% -$231K
CTSH icon
419
Cognizant
CTSH
$26.5B
$2.27M 0.02%
33,501
-424
-1% -$29.3K
STT icon
420
State Street
STT
$48.4B
$2.26M 0.02%
33,813
-1,506
-4% -$106K
APH icon
421
Amphenol
APH
$185B
$2.24M 0.02%
53,400
-6,558
-11% -$282K
KKR icon
422
KKR & Co
KKR
$89.1B
$2.22M 0.02%
36,022
-970
-3% -$58.9K
CVX icon
423
Chevron
CVX
$382B
$2.2M 0.02%
13,043
-154
-1% -$24.9K
TWST icon
424
Twist Bioscience
TWST
$5.32B
$2.18M 0.02%
107,360
-227,000
-68% -$4.99M
TROW icon
425
T. Rowe Price
TROW
$25.5B
$2.15M 0.02%
20,516
-1,819
-8% -$205K

Similar funds

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.